Suboptimal Dosing of β-Blockers in Chronic Heart Failure: A Missed Opportunity?
Background
The evidence base for the benefits of β-blockers in heart failure with reduced ejection fraction (HFrEF) suggests that higher doses are associated with better outcomes.
Objectives
The aim of this study was to report the proportion of patients receiving optimized doses of β-blockers, outcomes, and factors associated with suboptimal dosing.
Methods
This was a prospective cohort study of 390 patients with HFrEF undergoing clinical and echocardiography assessment at baseline and at 1 year.
Results
Two hundred thirty-seven patients (61%) were receiving optimized doses (≥5-mg/d bisoprolol equivalent), 72 (18%) could not be up-titrated (because of heart rate
Source: Journal of Cardiovascular Nursing - Category: Nursing Tags: ARTICLES: Brief Reports Source Type: research
More News: Bisoprolol | Cardiology | Cardiovascular | Heart | Heart Failure | Nurses | Nursing | Study